Alkermes (ALKS) Net Margin Growth (5y) (2015 - 2026)
Alkermes (ALKS) Net Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.20 Bn | 43.24 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.43 Bn | 39.78 Bn | 2.15 Bn |
| 3 | Zoetis | 32.03 Bn | 30.35 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.42 Bn | 19.76 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.05 Bn | 11.52 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.08 Bn | 9.92 Bn | - |
| 10 | Alkermes | 8.06 Bn | 7.41 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -67.00 |
| Mar 31, 2026 | -802.00 |
| Dec 31, 2025 | 2,807.00 |
| Dec 31, 2024 | -37,658.00 |
| Sep 30, 2024 | 2,059.00 |
| Jun 30, 2024 | 1,402.00 |
| Mar 31, 2024 | 4,249.00 |
| Dec 31, 2023 | -4,913.00 |
| Sep 30, 2023 | 194.00 |
| Jun 30, 2023 | 390.00 |
| Mar 31, 2023 | 1,506.00 |
| Dec 31, 2022 | 6,375.00 |
| Sep 30, 2022 | -198,250.00 |
| Jun 30, 2022 | -92,210.00 |
| Mar 31, 2022 | 2,303.00 |
| Dec 31, 2021 | 4,856.00 |
| Sep 30, 2021 | 2,492.00 |
| Jun 30, 2021 | 2,496.00 |
| Mar 31, 2021 | 4,047.00 |
| Dec 31, 2020 | 2,731.00 |